CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 136 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,177 | +135.1% | 2,091 | +72.7% | 0.00% | – |
Q2 2023 | $13,260 | +132500.0% | 1,211 | +5.3% | 0.00% | – |
Q1 2023 | $10 | +42.9% | 1,150 | 0.0% | 0.00% | – |
Q4 2022 | $7 | -99.8% | 1,150 | 0.0% | 0.00% | – |
Q3 2022 | $4,000 | +33.3% | 1,150 | 0.0% | 0.00% | – |
Q2 2022 | $3,000 | -82.4% | 1,150 | -79.0% | 0.00% | – |
Q1 2022 | $17,000 | -45.2% | 5,470 | -47.8% | 0.00% | – |
Q4 2021 | $31,000 | +675.0% | 10,470 | +810.4% | 0.00% | – |
Q3 2021 | $4,000 | -20.0% | 1,150 | 0.0% | 0.00% | – |
Q2 2021 | $5,000 | 0.0% | 1,150 | 0.0% | 0.00% | – |
Q1 2021 | $5,000 | -66.7% | 1,150 | -56.6% | 0.00% | – |
Q4 2020 | $15,000 | +50.0% | 2,650 | +89.3% | 0.00% | – |
Q3 2020 | $10,000 | +100.0% | 1,400 | 0.0% | 0.00% | – |
Q2 2020 | $5,000 | +25.0% | 1,400 | -25.5% | 0.00% | – |
Q4 2019 | $4,000 | -20.0% | 1,880 | +102.2% | 0.00% | – |
Q3 2019 | $5,000 | +66.7% | 930 | +116.3% | 0.00% | – |
Q2 2019 | $3,000 | -50.0% | 430 | 0.0% | 0.00% | – |
Q1 2019 | $6,000 | +100.0% | 430 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | -40.0% | 430 | 0.0% | 0.00% | – |
Q3 2018 | $5,000 | – | 430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 2,254,502 | $20,741,000 | 14.54% |
Versant Venture Management, LLC | 1,048,601 | $9,647,127,000 | 10.15% |
Abingworth LLP | 1,147,077 | $10,553,000 | 7.65% |
Omega Fund Management, LLC | 551,477 | $5,074,000 | 3.67% |
Opaleye Management Inc. | 665,000 | $6,118,000 | 1.96% |
DAFNA Capital Management LLC | 361,164 | $3,323,000 | 1.79% |
Boxer Capital, LLC | 1,012,986 | $9,319,000 | 1.70% |
Foresite Capital Management III, LLC | 600,000 | $5,520,000 | 1.55% |
NEXTHERA CAPITAL LP | 536,568 | $4,936,000 | 0.91% |
Perceptive Advisors | 2,685,882 | $24,710,000 | 0.82% |